Favor J, Layton D, Sega G, Wassom J, Burkhart J, Douglas G, Dearfield K, Brusick D
Hazleton Washington Inc., Vienna, VA 22182-1699, USA.
Mutat Res. 1995 Aug;330(1-2):23-34. doi: 10.1016/0027-5107(93)e0261-n.
This report describes a model for producing quantitative genetic risk assessments for human populations. The model is patterned after current methods used in cancer risk analysis. The risk to humans is expressed as the number of additional dominant genetic diseases added to the existing genetic burden, in the offspring of the exposed individuals.